Original Query: ALL
Previous Study | Return to List | Next Study

Juvenile Offender HIV Prevention and Drug Abuse Services (Day Treatment)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01922297
Recruitment Status : Completed
First Posted : August 14, 2013
Last Update Posted : August 25, 2015
National Institute on Drug Abuse (NIDA)
Information provided by (Responsible Party):
Howard Liddle, University of Miami

Brief Summary:
This study will determine the clinical effectiveness, moderators and mechanisms of change, and economic impact of an integrative, family-based intervention that concurrently targets change in HIV/Sexually Transmitted Disease (STD)-associated risk behaviors, drug abuse, delinquency, arrest and mental health outcomes for juvenile offenders committed to a juvenile justice day treatment program.

Condition or disease Intervention/treatment
Risk Behavior Substance Abuse Delinquency Other: Day Treatment MDFT-HIV Other: Day Treatment SAU

  Show Detailed Description

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 121 participants
Allocation: Randomized
Intervention Model: Factorial Assignment
Masking: Single (Outcomes Assessor)
Primary Purpose: Treatment
Official Title: Juvenile Offender HIV Prevention and Drug Abuse Services
Study Start Date : January 2010
Primary Completion Date : April 2015
Study Completion Date : April 2015

Resource links provided by the National Library of Medicine

MedlinePlus related topics: HIV/AIDS
U.S. FDA Resources

Arm Intervention/treatment
Experimental: Day Treatment MDFT-HIV
Multidimensional Family Therapy (MDFT)is an integrative treatment approach that has blended family therapy, individual therapy, drug counseling, and multiple systems oriented intervention approaches (Liddle 1999). DT-MDFT-HIV includes a state-of-the-art family-based HIV prevention component into the core MDFT intervention specifically targeting high-risk sexual behavior in clinical sample teens.
Other: Day Treatment MDFT-HIV
MDFT-HIV is a specialized intervention aimed at reducing risk factors for HIV-associated sexual behaviors. It builds protective behaviors in the adolescent's intrapersonal and interpersonal functioning, as well as those aspects of family functioning to reduce youths' high-risk sexual behavior. For instance, interventions target inadequate monitoring, parent-adolescent conflict, and parental disengagement - behaviors consistently associated with elevated HIV/STD risk. It facilitates positive and supportive family relationships, processes that can significantly reduce HIV/STD risk. Additionally, it aims to promote effective family communication about sexuality and safer sexual behaviors, among the most important protective factors against sexual risk taking behavior.
Other Name: DT-MDFT-HIV
Day Treatment SAU
The DT-Services as Usual (SAU) condition is primarily a peer group-based and individual approach that uses cognitive-behavioral principles and interventions. It is an adolescent substance abuse treatment and services consistent with those recommended for juvenile justice-involved drug abusing youth (Cooper & Bartlett 1998; National Institute of Justice, 2001).
Other: Day Treatment SAU
Substance abuse treatment and HIV prevention services are routinely provided to youth in the day treatment programs. The day treatment programs contract to local substance abuse and mental health providers for these services that are provided both within and outside of the day treatment setting. The intervention's specific features are similar to those found in the literature on outpatient peer-based group treatment for adolescent alcohol abusers (CSAT 1998). Specifically, it is based on a cognitive-behavioral group treatment model (Kaminer et al 1998; Marshall & Marshall 1993), with a comprehensive treatment package including individual counseling and treatment planning.
Other Name: DT-SAU

Primary Outcome Measures :
  1. Substance Use [ Time Frame: Changes in substance use from intake through the 24-month follow-up ]
    The Timeline Follow-Back Method, Personal Experiences Inventory and Urinalyses will be used to measure substance use

Secondary Outcome Measures :
  1. HIV Associated Sexual Risk Behaviors [ Time Frame: Changes in HIV Associated Sexual Risk Behaviors from intake to the 24-month follow-up ]
    Timeline Followback for Sexual Risk Behavior, Urinalysis for STD testing and HIV/STD Risk Assessment Measure

  2. Delinquency [ Time Frame: Changes in delinquency from intake through the 24-month follow-up ]
    Juvenile Justice records and the Service Utilization Interview

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   13 Years to 18 Years   (Child, Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes

Inclusion Criteria:

  • Between the ages of 13 and 18
  • Committed to a juvenile justice day treatment program
  • Meet criteria for substance use disorder on the DISC Predictive Scales
  • Any self-reported sexual activity within the past 6 months
  • At least one parent figure willing to participate in intervention and assessments

Exclusion Criteria:

  • Mental retardation or pervasive developmental disorders
  • Psychotic features
  • Current suicidality defined as Ideation + Plan + High intention to carry out plan

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT01922297

United States, Florida
University of Miami Miller School of Medicine
Miami, Florida, United States, 33136
Sponsors and Collaborators
University of Miami
National Institute on Drug Abuse (NIDA)
Principal Investigator: Howard A Liddle, EdD University of Miami

Responsible Party: Howard Liddle, Professor, University of Miami Identifier: NCT01922297     History of Changes
Other Study ID Numbers: 20090438
R01DA027216 ( U.S. NIH Grant/Contract )
First Posted: August 14, 2013    Key Record Dates
Last Update Posted: August 25, 2015
Last Verified: August 2015

Keywords provided by Howard Liddle, University of Miami:
HIV Associated Risk Behavior
Family based treatment
Multidimensional Family Therapy

Additional relevant MeSH terms:
Substance-Related Disorders
Chemically-Induced Disorders
Mental Disorders